| 发明名称 |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 摘要 |
The present invention relates to a method for preventing and/or reducing cellular and tissue damage caused by reactive oxygen metabolites (ROMs) released by phagocytic or endothelial cells in response to various infectious disease states or pathologies. The methods of the present invention contemplate reducing ROM-mediated damage by reducing the production and release of ROMs.
|
| 申请公布号 |
US6407133(B2) |
申请公布日期 |
2002.06.18 |
| 申请号 |
US20010833896 |
申请日期 |
2001.04.12 |
| 申请人 |
MAXIM PHARMACEUTICALS, INC. |
发明人 |
HELLSTRAND KRISTOFFER;HERMODSSON SVANTE;GEHLSEN KURT R. |
| 分类号 |
A61K45/00;A61K31/00;A61K31/015;A61K31/33;A61K31/355;A61K31/375;A61K31/4045;A61K31/417;A61K38/44;A61K45/06;A61P1/00;A61P9/10;A61P11/00;A61P25/16;A61P25/28;A61P29/00;A61P31/00;A61P31/14;A61P37/00;A61P37/02;A61P39/00;A61P39/06;(IPC1-7):A61K31/417 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
